Clinical Report: Machine Learning Expands Across Endocrinology

Overview

Machine learning (ML) applications in endocrinology have significantly increased, particularly in thyroid-related research, with 1,130 studies identified. While ML shows promise in imaging, risk prediction, and treatment-response modeling, challenges remain in validation and clinical implementation.

Background

The integration of machine learning in endocrinology is crucial due to the complexity of endocrine disorders and the need for precise diagnostic and treatment strategies. As the prevalence of conditions like diabetes and thyroid disorders rises, leveraging ML can enhance clinical decision-making and patient outcomes. However, the field faces challenges in standardization and validation of ML models.

Data Highlights

No numerical data available.

Key Findings

• 68% of ML studies focused on thyroid diseases, with significant applications in ultrasound evaluation.
• Deep learning models achieved diagnostic performance comparable to expert radiologists, reducing unnecessary biopsies by 27%.
• ML models demonstrated high accuracy in predicting malignancy and lymph node metastasis in thyroid disorders.
• In pituitary disorders, ML-based radiomics differentiated cystic adenomas with an AUC of 0.848.
• Adrenal ML studies showed high diagnostic performance, with some models achieving AUC values above 0.94.
• Limitations include lack of model transparency and reliance on retrospective designs, highlighting the need for high-quality research.

Clinical Implications

Healthcare professionals should consider the potential of ML to improve diagnostic accuracy and treatment strategies in endocrinology. However, attention must be given to the limitations of current ML applications, including the need for rigorous validation and interdisciplinary collaboration.

Conclusion

Machine learning holds significant promise for advancing endocrinology, but its successful integration into clinical practice requires careful validation and collaboration among specialists.

References

1. AACE Endocrine AI, AACE Endocrine AI is here: Why you need this now, 2026 -- Machine learning tool may help personalize type 2 diabetes treatment
2. AACE Endocrine AI, AACE 2026: Will AI replace endocrinologists?, 2026 -- AI in endocrinology: Promises, risks, and responsibilities
3. AACE Endocrine AI, AI in endocrinology: Promises, risks, and responsibilities, 2026 -- Machine learning tool may help personalize type 2 diabetes treatment
4. Diabetes Technology: Standards of Care in Diabetes—2026, PMC -- Standards of Care in Diabetes—2026
5. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management, PMC -- 2023 European Thyroid Association Clinical Practice Guidelines
6. aace endocrine ai — Machine learning tool may help personalize type 2 diabetes treatment
7. 7. Diabetes Technology: Standards of Care in Diabetes—2026 - PMC
8. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management - PMC
9. FDA Finalizes Guidance on Predetermined Change Control Plans for AI-Enabled Medical Device Software | Insights | Ropes & Gray LLP